The increase in morphine antinociceptive potency produced by carrageenan-induced hindpaw inflammation is blocked by naltrindole, a selective δ-opioid antagonist
@article{Ossipov1995TheII, title={The increase in morphine antinociceptive potency produced by carrageenan-induced hindpaw inflammation is blocked by naltrindole, a selective $\delta$-opioid antagonist}, author={Michael H. Ossipov and Carl J Kovelowski and Frank Porreca}, journal={Neuroscience Letters}, year={1995}, volume={184}, pages={173-176} }
52 Citations
Effects of spinal cholecystokinin receptor antagonists on morphine antinociception in a model of visceral pain in the rat.
- BiologyThe Journal of pharmacology and experimental therapeutics
- 2000
Data indicate that CCK, acting at the CCK(B) receptor, is involved in modulating morphine antinociception following a noxious visceral stimulus, however, CCK receptor antagonists no longer enhance morphine ant inociceptive effects after instillation of intracolonic TNBS, suggesting that visceral inflammation may lead to a reduction in spinal CCK release.
The analgesic effects of supraspinal mu and delta opioid receptor agonists are potentiated during persistent inflammation.
- BiologyThe Journal of neuroscience : the official journal of the Society for Neuroscience
- 2000
Results indicate that peripheral inflammatory injury alters the pharmacology of excitatory and inhibitory inputs that modulate the activity of RVM neurons in such a manner as to enhance the effects of opioid agonists in this region.
The Analgesic Effects of Supraspinal μ and δ Opioid Receptor Agonists Are Potentiated during Persistent Inflammation
- BiologyThe Journal of Neuroscience
- 2000
Results indicate that peripheral inflammatory injury alters the pharmacology of excitatory and inhibitory inputs that modulate the activity of RVM neurons in such a manner as to enhance the effects of opioid agonists in this region.
Contribution of Endogenous Enkephalins to the Enhanced Analgesic Effects of Supraspinal μ Opioid Receptor Agonists after Inflammatory Injury
- BiologyThe Journal of Neuroscience
- 2001
It is suggested that persistent inflammatory injury increased the release in the RVM of opioid peptides with preferential affinity for the δ opioid receptor, which can interact in a synergistic or additive manner with an exogenously administered μ opioid receptor agonist.
Effects of opioid receptor antagonists on the effects of i.v. morphine on carrageenin evoked c-Fos expression in the superficial dorsal horn of the rat spinal cord
- BiologyBrain Research
- 1999
Involvement of Gi/o proteins and GIRK channels in the potentiation of morphine-induced spinal analgesia in acutely inflamed mice
- BiologyNaunyn-Schmiedeberg's Archives of Pharmacology
- 2009
Differences in the transduction mechanism activated by MOR at postsynaptic level, probably related with GIRK channels activity, could participate in the potentiation of morphine-induced spinal analgesia in acutely inflamed mice.
Further evidence for the interaction of μ- and δ-opioid receptors in the antinociceptive effects of the dual inhibitor of enkephalin catabolism, RB101(S) A spinal c-Fos protein study in the rat under carrageenin inflammation
- BiologyBrain Research
- 2003
Opioid Pharmacology of Acute and Chronic Pain
- Biology, Psychology
- 1997
This work has suggested that neuropathic pain states are thought to be associated with increased spinal CCK content and, accordingly, reduced antinociceptive potency and efficacy of morphine, and that spinal levels of dynorphin are also Thought to be increased in conditions of chronic pain.
Synergy between the antinociceptive effects of morphine and NSAIDs.
- BiologyCanadian journal of physiology and pharmacology
- 2004
The synergy between morphine and NSAIDs could be related to different pathways of pain transmission, probably related to the different intracellular signal transduction mechanisms of action of opioid and non-opioid agents.
Persistent pain model reveals sex difference in morphine potency.
- Biology, PsychologyAmerican journal of physiology. Regulatory, integrative and comparative physiology
- 2006
These studies demonstrate sex-based differences in the effects of morphine on thermal hyperalgesia in a model of persistent inflammatory pain.
References
SHOWING 1-10 OF 22 REFERENCES
Cholecystokinin as a factor in the enhanced potency of spinal morphine following carrageenin inflammation
- BiologyBritish journal of pharmacology
- 1993
It is proposed that in normal animals, morphine may produce a maximal stimulation of the release of CCK such that exogenous CCK is unable to reduce further the analgesic effects under these conditions.
Activation of spinal delta-1 or delta-2 opioid receptors reduces carrageenan-induced hyperalgesia in the rat.
- BiologyThe Journal of pharmacology and experimental therapeutics
- 1994
Although NTB distinguishes between delta-1 and delta-2 opioid receptors, high doses may not effectively distinguish between delta and mu receptors, consistent with characterization of NTB as a selective delta- 2 receptor antagonist.
PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes.
- Biology, PsychologyProceedings of the National Academy of Sciences of the United States of America
- 1990
The results demonstrated that a CCK antagonist directed to the central CCK type B receptor potentiates the analgesic effects of opioids and nonopioid drugs at the spinal level, thus supporting the notion that CCK in the central nervous system may be an endogenous, physiological opioid antagonist.
Modulation of ~-mediated antinociception by ~ agonists: characterization with antagonists
- Biology
- 1989
Cholecystokinin antagonists selectively potentiate analgesia induced by endogenous opiates
- Biology, PsychologyBrain Research
- 1985
The analgesic effects of morphine, but not those of the enkephalinase inhibitor thiorphan, are enhanced in arthritic rats
- Biology, MedicineBrain Research
- 1983
Modulation of mu-mediated antinociception by delta agonists in the mouse: selective potentiation of morphine and normorphine by [D-Pen2,D-Pen5]enkephalin.
- BiologyEuropean journal of pharmacology
- 1989
Opioid δ-receptor involvement in supraspinal and spinal antinociception in mice
- BiologyBrain Research
- 1987